William John Sibold's Insider Trades & SAST Disclosures

William John Sibold's most recent trade in Madrigal Pharmaceuticals Inc was a trade of 22,009 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 5, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Madrigal Pharmaceuticals Inc
William John Sibold Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2025 22,009 22,009 - - Stock Option (Right to Buy)
Madrigal Pharmaceuticals Inc
William John Sibold Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2025 13,066 117,369 (0%) 0% 0 Common Stock
Madrigal Pharmaceuticals Inc
William John Sibold Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2025 50,000 104,303 (0%) 0% - Common Stock
Madrigal Pharmaceuticals Inc
William John Sibold Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2025 50,000 0 - - Performance Restricted Stock Units
Madrigal Pharmaceuticals Inc
William John Sibold Director, President and CEO Sale of securities on an exchange or to another person at price $ 335.24 per share. 24 Jan 2025 1,584 54,303 (0%) 0% 335.2 531,020 Common Stock
Madrigal Pharmaceuticals Inc
William John Sibold Director, President and CEO Sale of securities on an exchange or to another person at price $ 243.83 per share. 09 Sep 2024 6,363 55,887 (0%) 0% 243.8 1,551,490 Common Stock
Madrigal Pharmaceuticals Inc
William John Sibold Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2024 18,459 18,459 - - Stock Option (Right to Buy)
Madrigal Pharmaceuticals Inc
John William Sibold Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2024 12,250 62,250 (0%) 0% 0 Common Stock
Madrigal Pharmaceuticals Inc
John William Sibold Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2024 12,250 12,250 - - Market Stock Unit
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades